Literature DB >> 27578282

Good Things Come in Threes: Genetically Engineered Neural Stem Cells Mitigate Chronic CNS Autoimmunity.

David Pleasure1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27578282      PMCID： PMC5023387          DOI： 10.1038/mt.2016.157

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  13 in total

Review 1.  Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis.

Authors:  Lawrence Steinman; Scott S Zamvil
Journal:  Trends Immunol       Date:  2005-09-08       Impact factor: 16.687

2.  Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells.

Authors:  Sha Mi; Robert H Miller; Wei Tang; Xinhua Lee; Bing Hu; Wutain Wu; Yiping Zhang; Christopher B Shields; Yongjie Zhang; Steven Miklasz; Diana Shea; Jeff Mason; Robin J M Franklin; Benxiu Ji; Zhaohui Shao; Alain Chédotal; Frederic Bernard; Aude Roulois; Janfeng Xu; Vincent Jung; Blake Pepinsky
Journal:  Ann Neurol       Date:  2009-03       Impact factor: 10.422

3.  The farnesoid-X-receptor in myeloid cells controls CNS autoimmunity in an IL-10-dependent fashion.

Authors:  Stephanie Hucke; Martin Herold; Marie Liebmann; Nicole Freise; Maren Lindner; Ann-Katrin Fleck; Stefanie Zenker; Stephanie Thiebes; Juncal Fernandez-Orth; Dorothea Buck; Felix Luessi; Sven G Meuth; Frauke Zipp; Bernhard Hemmer; Daniel Robert Engel; Johannes Roth; Tanja Kuhlmann; Heinz Wiendl; Luisa Klotz
Journal:  Acta Neuropathol       Date:  2016-07-06       Impact factor: 17.088

4.  Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis.

Authors:  Alexandre S Basso; Dan Frenkel; Francisco J Quintana; Frederico A Costa-Pinto; Sanja Petrovic-Stojkovic; Lindsay Puckett; Alon Monsonego; Amnon Bar-Shir; Yoni Engel; Michael Gozin; Howard L Weiner
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

5.  Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis.

Authors:  Athena M Soulika; Eunyoung Lee; Erica McCauley; Laird Miers; Peter Bannerman; David Pleasure
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

6.  Neurotrophin 3 transduction augments remyelinating and immunomodulatory capacity of neural stem cells.

Authors:  Jingxian Yang; Yaping Yan; Yang Xia; Tingguo Kang; Xing Li; Bogoljub Ciric; Hui Xu; Abdolmohamad Rostami; Guang-Xian Zhang
Journal:  Mol Ther       Date:  2013-10-17       Impact factor: 11.454

Review 7.  Pathological mechanisms in progressive multiple sclerosis.

Authors:  Don H Mahad; Bruce D Trapp; Hans Lassmann
Journal:  Lancet Neurol       Date:  2015-02       Impact factor: 44.182

Review 8.  The primate autoimmune encephalomyelitis model; a bridge between mouse and man.

Authors:  Bert A 't Hart; Yvette van Kooyk; Jeroen J G Geurts; Bruno Gran
Journal:  Ann Clin Transl Neurol       Date:  2015-03-18       Impact factor: 4.511

9.  IL-10-dependent Tr1 cells attenuate astrocyte activation and ameliorate chronic central nervous system inflammation.

Authors:  Lior Mayo; Andre Pires Da Cunha; Asaf Madi; Vanessa Beynon; Zhiping Yang; Jorge I Alvarez; Alexandre Prat; Raymond A Sobel; Lester Kobzik; Hans Lassmann; Francisco J Quintana; Howard L Weiner
Journal:  Brain       Date:  2016-05-31       Impact factor: 13.501

10.  Neural Stem Cells Engineered to Express Three Therapeutic Factors Mediate Recovery from Chronic Stage CNS Autoimmunity.

Authors:  Xing Li; Yuan Zhang; Yaping Yan; Bogoljub Ciric; Cun-Gen Ma; Bruno Gran; Mark Curtis; Abdolmohamad Rostami; Guang-Xian Zhang
Journal:  Mol Ther       Date:  2016-05-16       Impact factor: 11.454
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.